Smith Group Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Smith Group Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-282,047	Closed	-$20.7M	–	353
2020 Q4	$20.7M	Sell	282,047 -14,650	-5%	-$1.09M	1.2%	33
2020 Q3	$23.1M	Buy	296,697 +292,557	+7,067%	+$20.1M	1.2%	24
2020 Q2	$230K	Sell	4,140 -70	-2%	-$3K	0.01%	159
2020 Q1	$125K	Hold	4,210	–	–	0.01%	196
2019 Q4	$152K	Hold	4,210	–	–	0.01%	218
2019 Q3	$115K	Hold	4,210	–	–	﹤0.01%	229
2019 Q2	$101K	Hold	4,210	–	–	﹤0.01%	238
2019 Q1	$111K	Sell	4,210 -92,150	-96%	-$2.18M	﹤0.01%	252
2018 Q4	$1.88M	Sell	96,360 -2,270	-2%	-$44.5K	0.07%	132
2018 Q3	$1.93M	Buy	+98,630	New	+$1.88M	0.05%	135

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Smith Group Asset Management's HZNP Position: Q1 2021 in Review

Smith Group Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 282,047 shares — an estimated $20.7M sold.

Smith Group Asset Management first reported a position in HZNP in Q3 2018 and held it in 10 quarters. The position peaked at $23.1M in Q3 2020. 516 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

Smith Group Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Smith Group Asset Management sold 282,047 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $20.7M.
Smith Group Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2018 and held it in 10 quarters.
Smith Group Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $23.1M in Q3 2020.
516 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on Smith Group Asset Management's 13F filing for Q1 2021, filed 7 May 2021.